Jazz Pharmaceuticals Plc (JAZZ)

Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.87%1,243.00	1,208.30	1,068.90	1,197.93	1,126.11
	4.80%407.90	389.20	352.70	406.21	-
Selling, General, and Administrative	4.80%407.90	389.20	352.70	406.21	-
Costs And Expenses	72.52%1,656.40	960.10	732.30	943.39	1,068.60
Operating Income/Loss	266.56%-413.40	248.20	336.60	254.54	57.51
Income/Loss From Equity Method Investments	100.00%-	-0.10	-	-0.06	-0.05
Income/Loss From Continuing Operations Before Tax	317.49%-458.90	211.00	299.20	208.47	9.04
Income Tax Expense/Benefit, Deferred	15.76%-44.80	-38.70	-66.20	-63.31	-271.41
Income Tax Expense/Benefit	35.36%24.50	18.10	6.10	4.96	-242.42
	350.73%-483.40	192.80	293.10	203.45	251.41
Attributable To Parent	350.73%-483.40	192.80	293.10	203.45	251.41
Basic Average Shares	2.37%64.70	63.20	61.90	-	60.70
Diluted Average Shares	6.77%64.70	69.40	66.10	-	61.61
Basic Earnings Per Share	345.25%-7.48	3.05	4.73	-	4.14
Diluted Earnings Per Share	369.06%-7.48	2.78	4.43	-	4.08